BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7450929)

  • 21. Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
    Roberts BL; Blake JW; Tobin T
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):257-65. PubMed ID: 981785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver disease and drug therapy.
    Black M
    Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolbutamide kinetics in a normal Indian population.
    Uppal R; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):95-6. PubMed ID: 3988400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic analysis of the interaction between dicoumarol and tolbutamide in man.
    Jähnchen E; Meinertz T; Gilfrich HJ; Groth U
    Eur J Clin Pharmacol; 1976 Sep; 10(5):349-56. PubMed ID: 61862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 28. Alcohol-drugs interaction in man: alcohol and tolbutamide.
    Carulli N; Manenti F; Gallo M; Salvioli GF
    Eur J Clin Invest; 1971 Sep; 1(6):421-4. PubMed ID: 5121732
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenylbutazone: factors influencing plasma concentrations.
    Davies DS
    J Int Med Res; 1977; 5 Suppl 2():15-9. PubMed ID: 913869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half life of intravenous tolbutamide in the serum of patients in medical wards.
    Sotaniemi EA; Huhti E
    Ann Clin Res; 1974 Jun; 6(3):146-54. PubMed ID: 4844125
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
    Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
    J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cimetidine on tolbutamide kinetics.
    Dey NG; Castleden CM; Ward J; Cornhill J; McBurney A
    Br J Clin Pharmacol; 1983 Oct; 16(4):438-40. PubMed ID: 6626438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].
    Gentile S; Porcellini M; Foglia F; Loguercio C; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):345-8. PubMed ID: 552849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.
    Robson RA; Miners JO; Whitehead AG; Birkett DJ
    Br J Clin Pharmacol; 1987 Jun; 23(6):772-5. PubMed ID: 3606937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on synthetic sweetening agents. XV. Metabolism of sodium cyclamate. Influences of phenylbutaone, phenobarbital, and tolbutamide on metabolism of sodium cyclamate in rabbits.
    Ichibagase H; Kojima S; Inoue K; Suenaga A
    Chem Pharm Bull (Tokyo); 1972 Jan; 20(1):175-80. PubMed ID: 5014543
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased clearance of tolbutamide from the blood of asthmatic patients.
    Sotaniemi E; Arvela P; Huhti E
    Ann Allergy; 1971 Mar; 29(3):139-41. PubMed ID: 5155517
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenylbutazone-warfarin interaction in the dog.
    Bachmann KA; Burkman AM
    J Pharm Pharmacol; 1975 Nov; 27(11):832-6. PubMed ID: 1491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of drug levels in man: phenylbutazone.
    Vesell ES; Page JG
    Science; 1968 Mar; 159(3822):1479-80. PubMed ID: 5753556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.